Introduction
The medical importance of HIV-1 and HIV-2 infections accelerated the detailed biochemical and immunological definition of structural and regulatory proteins of lentiviruses. Intensive work focused on the molecular process leading to the assembly of HIV-virions as one of the key mechanisms in the life cycle of HIV. Increasing attention has been paid to the group specific antigens of HIV-1. The HIV-1 gag open reading frame encodes a 55 kDa polyprotein which is subsequently processed into the mature, nonglycosylated matrix protein p 17 (MA), the capsid protein p 24 (CA); the nucleoprotein p 9 (NP) and a link protein p 6 (LI) [-25, 31, 41] . Cleavage of the gag precursor to yield the mature capsid proteins is at least in part specified by the viral protease (PR) [2, 19, 20, 23] . The viral protease is encoded by the NHz-terminal region of thepol open reading frame which contains precursor forms necessary for viral replication. The pol gene products are initially synthesized as a 160 kDa gagpol fusion protein, which results from a ( -1) translational frameshift occurring at a relatively low frequency in the gagpol overlapping region [14] . This polyprotein precursor molecule may be autocatalytically processed into the 9 kDa protease (PR), the reverse transcriptase (RT), the integrase (IN) and mature core proteins. As for other retroviruses [13, 41] the NH2-termini of both, the 55 kDa and the 160 kDa precursor proteins are myristylated.
The exact role of the myristyl-moiety and the NHz-terminus of the capsid presursor molecule is not clear to date, although it has been identified at the amino-terminus of a number of retroviral gag products 41] . Myristylation of the gag precursor typically occurs cotranslationally [43] and is specified by the NHz-terminal glycine residue next to the methionine derived from the initiation codon [15] . Obviously, the myristic acid moiety at the amino terminus of p 17 is essential for the release of HIV virus particles [13] . Functions as membrane anchor [14] or signal for intracellular transport [33] have been suggested. As has been also shown in type C Moloney murine leukemia viruses (Mo-MuLV), myristylation of the HIV-1 p 55gag polyprotein precursor is essential for its membrane localization and assembly of capsid protein into discrete particles at the plasma membrane. Changes in the p 17 amino-terminal glycine of provirus clones abolish myristylation of the HIV-1 precursor proteins and prevent virus particle release from transfected cells. In contrast to Mo-MuLV and type D Mason-Pfitzer monkey virus (MPMV), processing of the p 55 capsid precursor is not inhibited in myristylation deficient variants of HIV-1 proviral Studies on the HIV-1 gag gene product 119 clones [9] . Several groups investigated the role of p 55 in the assembly of virus particles when expressed in eucaryotic cells such as yeast [19] and mammalian cells using plasmid vectors [37] or recombinant vaccinia virus [11, 29, 36] . Budding of virus-like particles has recently been shown from a baculovirus vector in insect cells [-3, 6] .
Due to its group specificity and its particle forming capacity, the HIV core antigen is a promising candidate for vaccine development. As known from other systems such as hepatitis B virus, particulate antigens are highly immunogenic and possess intrinsic adjuvant properties [26] . High antibody titers to p 55 during early stages of infection, the inhibiting activity of reactive monoclonal antibodies in vitro [30] and the significance of core proteins in the elimination of infected cells by cytolytic T-cells [28] support the role of p 55 gag in future candidate vaccines. For this reason we conducted a detailed comparative analysis of the particle forming capacity of the HIV-1 core antigen. Identical DNAconstructs containing the entire gag in its natural configuration were established and altered (i) into a myristylation deficient form, (i0 combined with the protease, (iii) either in its natural configuration or in frame to p 17/p 24 and (iv) fused to the entire pol coding sequence. The different polypeptides were expressed in E. eoli as well as by recombinant vaccinia-and baculoviruses in mammalian and insect cells, respectively. The experiments reported here compare the influence of myristylation and protease activity on HIV-1 core expression and particle assembly in various expression systems in order to identify optimal conditions for the formation of recombinant core particles. Evidence is presented for the induction of a core specific humoral immune response after immunisation of rabbits with purified core particles.
Materials and methods

Plasmid DNA
A DNA clone containing HIV-1 sequences, pBH 102, was kindly provided by Prof. Gallo, NIH, Bethesda, MD, U.S.A. The baculovirus expression vector pVL 941 was provided by Dr. Summers, Texas A &M University, College Station, TX, U.S.A. All reported were propagated in Eschericha coli strain JM 109.
Ce//s
Green monkey kidney CV-1 cells, SW 480 colon carcinoma cells and B 143 cells were grown in Eagles minimal essential medium (MEM) containing 5% fetal calf serum. Spodoptera frugiperda (Sf9) insect cells were propagated in TC 100 medium (GIBCO/BRL, Federal Republic of Germany) supplemented with 10% fetal calf serum.
Sera and monoclonal antibodies
Production and mapping of p24 specific mouse monoclonal antibody 16/4/2 used for immunoblotting was previously described by Wolf et al. [26] . A p 17 specific mouse monoclonal antibody was kindly provided by Prof. Chandra, University of Frankfurt, Federal Republic of Germany. A rabbit serum directed against the HIV-1 protease was obtained 
Construction of recombinant plasmids
In order to obtain precise NHz-termini of the capsid precursor we inserted a 62 bp oligonucleotide, GATCCATGG GTGCGAGAGC GTCAGTATTA AGCGGGGGAG AATTAGATCG ATGTCGACCT GCA, encoding the 15 NHz-terminal amino acids of p 55gag into the Barn HI~Hind III site of the pUC 8 vector. The restriction sites Cla I and Sal I in the 3' position within the oligonucleotide were used to complete the gag reading frame by insertion of a 1694 bp Cla I/Hinc II fragment resulting in plasmid pUC8 p55.
For expression of the myristylation deficient capsid precursor, we replaced the 47 bp Bam HI/Cla I fragment encoding the amino-terminal part of p 17 by a corresponding DNA fragment, GATTCGTGCA CGCCA TGGCT GCGAGAGCGT CAGTATTAAG CGGGGGAGAA TTAGAT. A G to C transition alters the NHz-terminal glycine residue into an alanine thereby destroying the myristylation signal sequence (pUC8 p55 M-). The correct sequence was verified by double strand sequencing using a T 4 polymerase sequencing kit (BRL).
To express p 55 gag with the exact protease polypeptide (PR) without additional carboxy-terminal polymerase (po/) sequences we inserted a synthetic polylinker sequence, AATTCGGATT CGTTGACCTG CAGTAATTAA TTAGATCTCG AGCCCGCCTA ATGAGCGGGC TTTTTTGAGC TCA into the Eco RI/Hind III restriction sites of pUC 8. This linker fragment contained stop codons in all reading frames (italics) and a procaryotic rho independent transcription termination signal (pUC 8 stop) to increase the production of recombinant proteins in E. coli. A 402 bp Nta IV~Bali fragment including the entire protease reading frame was inserted into the Hinc II site of pUC 8 stop to yield pUC 8 PR stop. For insertion of the p 55 gag coding sequence, we fused the pUC8 p55 derived Barn HI/BclI fragment with the Barn HI/ BclI fragment of pUC 8 PRstop to create pUC8 p55PR.
To combine the gag and the protease gene in the same open reading frame, the BglII restriction site of pUC8 p55 PR was opened, filled enzymatically using the Klenow fragment and religated, thereby creating an additional Cla I site. The resulting plasmid was called pUC8 p55 PR-FS. The enforced frameshift replaced the carboxy terminal 63 amino acids ofp 15 by the HIV-1 protease. The regular ribosomal frameshift site is located 6 bp upstream of the generated Cla I site.
To align both the myristylation competent and incompetent forms of the gag gene with the entire pol gene, we replaced the 437bp BglII/SalI fragment of pUC8p55 and of pUC8 p55 M -by a 3727 bp BglII/Sal I fragment including p 15 and the complete pol gene to create pUC8 p55 Pol and pUC8 p55 M -Pol.
For production of the recombinant proteins and following characterization in E.coli, we subcloned the coding sequences into a NcoI/SalI digested pTRC99 ATG-vector to avoid expression of disturbing LacZ derived NH2-terminal sequences.
To establish recombinant vaccinia viruses, the pUC derived gag-gene constructs were subcloned into the BglII/SalI digested pAvB vaccinia transfer vector [27] to create pAvBp 55, pAvB 55 M -, pAvBp 55 PR, pAvBp 55 Pol, pAvBp 55 M -Pol and pAvBPR-FS. For expression by recombinant baculovirus, we subcloned two relevant inserts, encoding p 55 and for comparison p55 PR (Fig. 1) , into the Bam HI site of the transfer vector pVL 941 . The basic gene constructs and the expression of the polypeptides in the respective expression systems are summarized in Fig. 1 . 
Construction of recombinant baculovirus
Sf9 cells were cotransfected with mixtures of infectious Autographa califonica nuclear polyhedrosis virus (AcMNPV) DNA and CsC1 purified [34] transfer vector DNA as described by Smith et al. Resultant progeny baculovirus was used to produce plaques in Sf9 cell monolayers. Plaques lacking polyhedrin structures were selected, purified by further plaque assays and used to produce virus stocks.
Analysis of recombinant polypeptides
IPTG induced recombinant bacteria were harvested and resuspended in lysis buffer as described by Sambrook et al. [34] . CV-1 cells were infected with wild type vTT or recombinant vaccinia virus at 10-20pfu per cell and incubated at 37°C for 24h in serum free MEM. Infected cells were harvested and resuspended in boiling mix. Monolayers of Sf9 cells were infected with wild type AcMNPV or recombinant baculovirus at a multiplicity of 5-10 pfu/cell and incubated at 28 °C for 1-5 days. Cells were harvested and suspended in the lysis buffer. Supernatant was, without concentration of the recornbinant protein, directly mixed with lysis buffer. Protein extracts were boiled for 5 rain at 100 °C and analyzed by SDS-PAGE and Western blotting [21] . Immunological detection was performed using monoclonal antibodies directed to p24 [44] , p 17 and a pool of AIDS patient sera.
Electron microscopy
Infected SW 480 and Sf9 cells were harvested with a cell scraper, washed with phosphate buffered saline (PBS) and then fixed for 2h with 2.5% glutaraldehyde in PBS. Cells were washed with PBS and postfixed for 1 h with osmium tetroxide in PBS. After washing in PBS and in distilled water, fixed cells were stained with 1% uranyl acetate in 20% acetone for 30 rain. Following dehydration in a graded series of acetone cells were embedded in Spurr's low-viscosity resin. Sections of 25 to 75 nm thickness were cut with a diamond knife and mounted on uncoated copper grids. The sections were poststained with 100 mmol Pbcitrate pH 12.6. All pictures were taken with Siemens Elmiskop 101 electron microscope.
The magnification was calibrated with a cross line grating replica.
Gradient sedimentation analysis
Supernatants of Sf9 cells infected with the recombinant baculoviruses b-p55 and b-p55 PR were collected 5 days p.i. from synthetic medium lacking FCS. Enrichment of core particles from precleared culture supernatant (3300 × g) was achieved by a Ultrasette-Filtron filter membrane (Satorius, Federal Republic of Germany) after the protocol of the manufacturers. 2 ml aliquots of the concentrated material was layered onto a 12 ml 10-60% sucrose gradient in 10 mM phosphate buffer pH 7.5 containing 0.15 M NaC1 and run at 20,000 rpm for 2 h in a Kontron TFT 4t. 14 rotor. Fractions (0.7 ml) were collected and directly assayed by conventional Western blot analysis. The yield of recombinant gag particles was determined using a commercial p 24/p 55 specific antigen capture assay (Abbot).
Reverse transcriptase assay
Supernatants of uninfected SW 480 cells and cells infected by the recombinant vaccinia viruses v-p55, v-p55M-Pol and v-p55Pol (10pfu/cell) were collected 2 days p.i. and precleared in a Kontron A 8.24 rotor for 15 min with 8000 rpm. The supernatant was layered onto a 2ml 37% sucrose cushion and ultracentrifuged at 5°C for 2h at 20,000rpm in a Kontron TFT41.14 rotor. The supernatant was discarded and the pellet was assayed for RT activity in a reverse transcriptase test using poly rA:dT and Mg ++ as described previously [10] .
Results
Basic constructs and concepts
In order to conduct a detailed comparative analysis of the p 55 particle forming capacity in different eucaryotic expression systems, we established a series of gag-gene constructs in the p U C vector system. In addition to the authentic p 55 gag gene (pUC8 p55), a m u t a n t f o r m of the gag precursor lacking the NH2-terminal myristylation signal sequence was constructed altering the glycine residue at position 2 of the amino acid sequence to alanine (gly to ala, p U C 8 p 5 5 M -) . The effect o f proteolytic processing on gag expression and particle formation was investigated by adding the protease (PR) coding sequence to the gag gene (/) in its natural configuration (pUC8 p55 PR) and (ii) in frame to p 55 (pUC8 p55 PR-FS). Finally, we added the entire pol gene to the "p 55"
and "p55 M -" gene-constructs to reveal the proteolytic capacity o f the HIV-1 protease in the complete 160 kDa gagpol polyprotein and to investigate the effect of myristylation on the processing of the precursor molecules. Using identical gag-gene constructs the level of HIV-core expression, proteolytic events and efficiency of particle formation could be determined and directly compared in different vector systems. Basic constructs and results described in the results are summarized in Fig. 1 .
Expression and biochemical analysis of p 55 and p 55-derived polypeptides in E. coti
After subcloning of the gag-gene constructs into the ATG-vector pTRC 99, recombinant proteins were expressed in E. coli (Fig. 1) . Immunoblot analysis using different p 24 and p 17 specific monoclonal antibodies reve, aled that all bacterial clones except pTRC p55 PR-FS expressed the authentic p 55 kDa gag precursor. Significant, but not complete processing was observed in lysates of p55 PR-, p55 Pol-and p55 M -Pol-recombinant bacteria (data not shown). Reverse transcriptase activity was measured in both bacterial clones, containing the entire polymerase gene (p55 Pol; p55 M -Pol).
In contrast, complete processing of the 65kDa p55PR precursor was achieved expressing the PR-gene in frame with the gag gene (p%RCp55PR-FS). The p 24/25 cleavage products were clearly visible in a SDS-PAGE stained with coomassie brilliant blue and could easily be detected by ,conventional Western blot analysis using p 24 specific monoclonal antibodies. Further detection of p 17 and the protease (9 kDa) by a monoclonal antibody directed to p 17 and a monospecific peptide serum directed to protease sequences confirmed the complete processing (data not shown).
Alteration of the myristylation signal sequence did not affect p 55 expression in E. eoli. Neither sucrose gradient sedimentation analysis performed with culture supernatants of recombinant bacteria or cell extracts, nor electron microscopy analysis performed with recombinant bacteria gave any 1hint on HIVcore particle formation in E.coli (data not shown).
Expression and biochemical analys& of p 55 and related constructs by recombinant vaccinia virus
Expression of the described constructs in CV-1 cells by recombinant vaccinia viruses was a fast approach to evaluate parameters involved in processing and core particle assembly (Fig. 1) . The recombinant vaccinia viruses (v-p55, vp55 M -, v-p55 PR, v-p55 PRFS, v-p55 Pol and v-p55 M -Pol) correspond exactly to the bacterial expression clones mentioned earlier. As shown by Western blot analysis ( Fig. 2A) , infection of CV-1 cells with v-p55, v-p55 M -and vp55 PR resulted in the expression of a 55 kDa and, to a smaller extent, of a 41 kDa protein. Addition of the exact HIV-1 protease coding sequence (vp55 PR) was not sufficient for detectable processing of p 55gag in CV-1 cells ( Fig. 2A, lanes 5 and 12) . The v-p55PR derived 41 kDa protein was clearly recognized by a p 17 specific monoclonal antibody (Fig. 2 A, lane 2) . For this reason, the production of p 41 was, at least partially, rather due to a suggested premature translational stop signal near the COOH-terminal part of the p 24 coding sequence [93 than to HIV-mediated proteolytic events. Kinetical studies, following the infection over a period of 48 h did not show any specific, protease mediated processing, although the PR coding sequence was verified by D N A sequencing. In contrast to some previous reports [4, 363, we found significant processing when the entire pol reading frame was added to the gag gene. Unprocessed p 55 gag, p 24/25 and different gag-processing intermediates with an estimated molecular weight of 40-41 kDa could now easily be detected in cell lysates (Fig. 2 A, lanes 6 and 7) . Using a pool of sera from AIDS patients, p 17 could be shown in addition to the polypeptides mentioned earlier (Fig. 2 A,  lanes 13 and 14) . As clearly demonstrated by analyzing extracts of v-p55 M -Pol infected CV-1 cells, processing was not dependent on previous myristylation of the gag precursor molecule. For comparison expression of p55 PR-FS resulted in an almost efficient processing of the core precursor in the vaccinia expression system (Fig. 2 B) . Sedimentation studies performed with culture supernatants and following Western blot analysis of the precipitated antigens gave identical results as (Fig. 3) . These results gave first evidence (i) for the release of particulate aggregates, that (ii) need NHz-terminal myristylation for the budding from the infected cells into the culture supernatant.
Requirements for budding of immature particles from mammalian cells infected by recombinant vaccinia virus
Budding of p 55 core particles (100-160 nm in diameter) from the plasma membrane and release into the culture medium was detected by electron microscopy after infection of SW 480 cells with v-p55, v-p55 PR and v-p55 Pol (Figs. 1 and  4) . The lack of myristylation (v-p55 M -, v-p55 M -Pol) at the NH2-termini apparently prevented targeting of the precursor polypeptides to the plasma membrane, confirming that myristylation of the polyprotein precursor is essential for its membrane localization and consecutive particle formation. Assembly was also abolished when the HIV-protease was expressed in an artificial construct in frame with p 55 (v-p55 PR-FS; data not shown). Analysing v-p55 Pol infected cells morphologically, we clearly detected p 55 particle formation and budding of recombinant particles into the culture supernatant. However, using the conventional vaccinia expression system, the yield of recombinant immature core particles was not sufficient for preparative scale fermentation. (Fig. 4 B) . Plasma membranes with a thickness of 6-7 nm (Fig. 4 A) formed spherical vesicles, the cytoplasmic site was coated by an electron-dense layer with a thickness of 14-17 nm. Occasionally, this layer exhibited an additional, more electron dense border line (Fig. 4 E) . The electron dense "15 nm" layer was typically interrupted at the site of budding (Fig. 4 E and F) . Essentially, all p55 gag particles produced in the vaccinia system showed an electron-translucent lumen which exhibited by far less granular components that the cytoplasm. The content of fibrous material was similar to that of the cytoplasm.
Expression and biochemical analysis of gag and related constructs in the baculovirus expression system
To increase the yields of recombinant gag-particles and to analyze adverse effects of HIV protease mediated processing on particle formation, two of the basic constructs, pVL p55 and pVL p55 PR, were expressed by a recombinant baculovirus in insect cells. Massive production of recombinant p 55 was achieved by infection of Sf9 cells with b-p55 recombinant baculovirus (Fig. 5) . It is noteworthy that unprocessed capsid precursor could be easily detected on immunoblots analyzing infected cells and in culture supernatants harvested 5 days p.i. without prior concentration. In parallel to high expression, proteolytic digestion of the capsid precursor by cellular or AcMNPV specific proteases could be observed in cellular extracts. In contrast to the vaccinia expression system (v-p55 PR; Fig. 2 A, B) , addition of the HIV-1 protease gene (b-p55 PR) resulted in complete processing of the p 55 precursor molecule in the baculovirus vector system.
Budding of immature p55 gag particles following expression of the capsid precursor by recombinant baculovirus
For analysis of the p 55 particle forming capacity, Sf9 insect cells were infected with b-p55 and, for comparison, with b-p55 PR. Infected cells were examined by electron microscopy (Fig. 6) . B-p55 infected cells showed multiple lentivirus-like budding of particles with 100-160 nm in diameter strongly resembling those budding from v-p55 and vp55Pol infected cells at the cell membrane surface (Fig. 4) . These structures were not detected in Sf9 cells infected by b-p55 PR and with wild type AcMNPV (data not shown). Assembly of the budding structures occurs at the cytoplasmic site of the plasma membrane. No particles or particulate structures were detected intracellularly. Production of the budding particles was abundant, leading to the release of single particles (Fig. 6 A) and to oligomeric aggregation (n = 2-4; Fig. 6 B) caused by incompletely dissociated complexes of budding structures or by monomeric particles fused immediately following the budding event. The structures dissociating from the cell membrane differed slightly in size and shape.
Immature particles, produced in Sf9 cells showed an electron translucent center, which was covered by a dark, electron-dense ring and an outer 14-17 nm medium grey regular shell. The b-p55 derived particulate structures were surrounded by a 6-7 nm plasma membrane derived from the infected cell. Within the lumen of p55 gag particles formed by the baculovirus system, electron-dense granules with diameters of about 15-20 nm were observed (Fig. 6) . These extracellular p55 gag particles were similar to structures previously described as immature HIV-1 virions [5, 16] . Ultrathin section electron microscopy performed with b-p55 PR infected cells revealed a dramatic decrease in p 55 particle formation, possibly due to the observed complete intracellular processing of the gag-precursor (Fig. 5) , thus confirming that complete intracetlular processing prevents core particle formation.
In order to confirm p 55 particle formation and shedding of the particulate structures into the culture medium, we performed sucrose gradient sedimentation analyzing the culture supernatant of Sf9 cells harvested 1-5 days after infection with b-p55. Fractions collected from the gradient were analyzed by immunoblotting followed by densitometric scanning. Highest yields of budding particles were obtained from supernatants harvested 5 days p.i. (Fig. 7) . Specifically detected bands of a higher molecular weight might represent oligomerized p 55 precursor proteins. Signals of a reduced molecular weight might be due to a not specific degradation of the core precursor protein by cytoplasmic proteases randomly packaged into the core particles during the budding process. Negative staining and examination by electron microscope of the antigenic peak fractions demonstrated particulate core antigens at a sucrose density of 1.16-1.19 kg/1. Particulate structures were budding into the culture supernatant to an estimated concentration of 20-30mg/1. Peak fractions corresponded to a major 55 kDa protein species which was specifically detected in Western blots by monoclonal antibodies to p 24 (Fig. 7) . In gradients performed with b-p55 PR derived culture supernatants, this peak fraction, containing particulate structures was missing (data not shown). These data clearly confirmed that (/) p55 gag particles are budding from b-p55 infected Sf9 cells into the culture medium and that (i/) particle formation is considerably reduced by HIV-1 protease mediated processing as demonstrated in b-p55 PR infected Sf9 cells. 
Immunogenicity of immature H I V virus-like particles
To demonstrate the immunogenicity of HIV-1 virus like particles, supernatants of b-p55 infected Sf9 cells were harvested and the immature particles were partially purified as described in Material and methods. Primary immunisation of two rabbits was performed using 67 ~tg of HIV-core antigen in complete Freund's adjuvant, followed by two booster injections with the same antigen dose in incomplete Freund's adjuvant after 2 and 6 weeks. Ten days after each immunisation serum samples were tested for anti p 24 IgG production by a commercial antigen specific ELISA (Behringwerke AG, Marburg, Federal Republic of Germany). Antibody titers following the primary and booster injections are shown in Fig. 8 . The induced antibody titers were similar in both animals. The animals developed a strong anamnestic response following the first booster injection reaching titers in excess of 1/105. A further booster injection did not markedly increase the response.
Discussion
Intrinsic adjuvant properties of particulate antigens are indicated by successful and routine application of recombinant 22 nm hepatitis B virus (HBV) surface antigen (HBsAG) particles as a protective vaccine in humans [40] . Particle formation was also reported for the production of HBV core antigen in E. coli and for the capsid precursors of several retroviruses and retrovirus-like particles expressed in eucaryotic expression systems [1, 7, 17, 18] . Autologous and chimeric Ty-particles were producted in yeast cells and purified for the application in immunization experiments and clinical studies [27] . Vaccine mediated induction of an extensive humoral and cellular immune response to the HIV-1 core proteins might prove important in HIV vaccine development. The HIV-1 group specific antigen is highly conserved amongst different HIV-1 and HIV-2 isolates and was characterized in the past as an important target of cell mediated [28, 42] and humoral immunity [30, 44] . We suggest that HIV-1 core particles themselves or products derived by adding additional sequence information are well suited as a safe and effective candidate vaccine. This study t 32
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aimed at investigating the parameters (e.g., HIV protease mediated processing or amino-terminal myristylation of the gag precursor) involved in budding of HIV-1 core particles after expression of artificial gag-gene constructs in various expression systems. In order to optimize HIV-1 core particle formation, different procaryotic and eucaryotic expression systems were compared. For optimal conditions of comparison, identical basic constructs were used for the production of different gag derived recombinant proteins. Core particle formation was not found in E. coli. One explanation could be the lack of posttranslational modifications which occur in authentic HIV infections [8, 41] , but not in E. coli. As confirmed by our experiments analysing v-p55 and v-p55 M -infected SW480 cells, glycine dependent NH2-terminal myristylation is essential for the budding of 100-160 nm immature p 55 particles (Fig. 1) . In contrast to the nuclear localization of unmyristylated p 55 produced in the baculovirus system [6], we could not detected an accumulation of particulate structures in the nucleus of v-p55 M -infected SW480 cells. Interestingly, amino-terminal myristylation of the gagpol precursor is not an absolute prerequisite for consecutive processing. This is shown by the processing of the core precursor in v -p 5 5 M -P o l infected CV-1 cells thus underlining major differences in the capsid morphogenesis between lentiviruses and type D retroviruses 1-8] (Fig. 2 A) .
Comparing both of the tested eucaryotic expression systems with respect to their p 55 particle forming capacity, we conclude that budding of immature gag particles is available from v-p55 infected mammalian cells as well as from Sf9 insect cells infected with a p 55 recombinant baculovirus. Detailed morphological analysis of p55gag particles budding from infected SW480 and Sf9 cells by ultrathin section electron microscopy demonstrated a fine structure very similar to the immature gag particles detected in authentic HIV infections [5] . This proposes a common mechanism for assembly of immature particles at the cytoplasmic side of the plasma membrane (Figs. 4 and 6 ). However, we found dramatic differences in the amounts of budding of immature core particles between the expression systems tested. Corresponding to the fulminant expression of p 55 in b-p55 infected cells, we found cluster-like accumulations of gag molecules at the inner cell membrane. A cluster of membrane bound gag precursor molecules results in hotspots of budding particles (Fig. 6) . Due to the abundant budding, a considerable part of the detected free particles produced from b-p55 infected insect cells is specified by oligomeric aggregates. In contrast, we find only small amounts of single, not oligomerized p 55 particles budding from the plasma membrane of v-p55 infected SW 480 cells, possibly due to the significantly weaker expression of the gag precursor in the vaccinia system. Based on densitometric analysis of immunoblots we found a 50 fold excess of gag-protein synthesis in the baculovirus system (b-p55) as compared to the production of the core precursor by recombinant vaccinia virus in mammalian cells (data not shown). According to the described existence of cellular myristyl moiety receptor molecules [32, 33] , a reduced number of these receptors in the tested mammalian cells might be responsible for the comparably low yield of p55 gag particles in the vaccinia virus system. Moreover, differences in growth conditions between Sf9 cells (28 °C) and SW480 cells (37 °C) might influence the membrane fluidity and consequently the formation of gag-particles.
Addition of PR-or pol-coding sequences to the gag gene did not provide for the synthesis of particles that resemble naturally occurring mature capsid structures including the typical conical p 24 core [5, 16] . Interestingly, addition of the exact PR coding sequence to the gag gene in its original reading frame (v-p55 PR) was not sufficient to induce significant processing of the core precursor in the vaccinia virus system (Fig. 2 A) . This unexpected result is in agreement with findings of Shioda et al. [36] ), but is in clear contrast to the observed complete processing of the gag-precursor in extracts of b-p55 PR infected Sf9 cells (Fig. 5) . Addition of the entire pol coding sequence to the gag gene and expression by vaccinia viruses (v-p55 Pol, v-p55 M -Pol) resulted in a significant, but not complete processing of the polyprotein precursors, that resembled the authentic situation in HIV-infected H 9 cells. This strongly indicates the involvement of regions COOH-terminal from the actual PR-domain in efficient formation of enzymatically active protease dimers (Fig. 2 A) . In contrast, complete processing of the gag precursor shown by b-p55 PR infected Sf9 cells (Fig. 5, lane 3) and by v-p55 PR-FS infected mammalian cells (Fig. 2 B) drastically reduced core particle formation (Fig. 1) . We propose, that dimerization of monomeric PR-domains, suggested to be necessary for complete processing of precursor molecules, which is not found in HIV infected cells, :requires high intracellular concentrations of the gag PR-readthrough proteins within the cell. Such concentrations possibly are only reached in artificial expression systems like, e.g., b-p55 PR infected Sf9 cells or in CV-1 cells infected with the v-p55 PR-FS vaccinia virus.
However, even partial processing did not finish the core maturation process. As demonstrated in a number of ultrathin sections, we could only find core particles budding from the plasma membrane described as immature virus particles by Gelderblom et al. [5] . These results clearly indicate, that the synthesis of mature capsids in artificial expression systems can not be achieved by simple addition of the protease or polymerase gene to the gag open reading frame. Recent publications described the synthesis of gag particles containing an electron dense core and HIV-RNA using a vaccinia driven expression system [11] and in stable transfection experiments [12] . A common feature of both experiments is the use of DNA constructs including, in addition to the PR coding sequence, an RNA packaging signal, located only few basepairs upstream of the p 55 coding sequence [22] . In contrast, using gag sequences lacking the packaging signal sequence, we could not find RNA packaged in our gag particle preparations in Nothern blot analysis (data not shown). Taken together, these observations suggest, that viral HIV RNA containing the packaging signal is at least partially involved in the capsid maturation process.
Immunological evaluation of immature gag particles purified from b-p55
infected Sf9 cells showed a high immunogenicity in rabbits. Preliminary results, using p 55 recombinant vaccinia viruses (v-p55) for immunisation of rabbits gave significantly lower titers of specific antibodies suggesting that recombinant core particles were more immunogenic than the vaccinia constructs (unpubl. data). Taken together, we conclude that empty immature p55gag particles lacking viral RNA and produced by recombinant baculovirus are well suited as a noninfectious vaccine component. Parallel studies try to identify regions in the gag precursor that can be exchanged by immunologically relevant epitopes encoded by other HIV-1 genes without disturbing the p 55 particle forming capacity. This approach aimed at extending the immunological spectrum of the p55 gag derived particles by inserting cytotoxic and helper T-cell determinants as well as neutralizing epitopes such as the gp 120 principal neutralizing determinant V3 (PND). Adverse side effects such as gp 120 dependent, antibody mediated enhancement of infection or the induction of immune suppresive effects would be excluded. The safety of engineered particulate vaccines would be guaranteed by the lack of viral LTR elements and primer binding sites. Moreover, deletion of the RNA packaging signal, the lack of enzymes (PR, RT, IN) and essential regulatory proteins (Tat, Rev, Vif) important for a possible recombination to infectious particles would enhance the safety of such a candidate vaccine.
